National Institutes of Health: Lymphoma, Large B-Cell, Diffuse trials
The registry lists 106 Lymphoma, Large B-Cell, Diffuse studies with National Institutes of Health as lead sponsor. 8 are open to participants now and 34 have results posted.
Early Phase 1 1Phase 1 64Phase 2 51Phase 3 3No phase 1(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaCompletedNCT00003970Phase 1
- Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
- Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00003210Phase 2
- Bryostatin and Vincristine in B-Cell MalignanciesCompletedNCT00003166Phase 1
- Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00002649Phase 3
- Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell LymphomasCompletedNCT00001237Phase 2